Standard Biotools Inc.
LAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001162194
No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Standard Biotools Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 138 | 113 | −25 |
| Shares | 59.4M | 57.6M | −1.78M (−3.0%) |
| Value | $268.7M | $354.4M | +$85.7M (+31.9%) |
New holders (9)
Institutions that held Standard Biotools Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ExodusPoint Capital Management, LP | 57,241 | $353.0K | 0.01% |
| DuPont Capital Management Corp | 45,733 | $282.0K | 0.01% |
| Cruiser Capital Advisors, LLC | 25,000 | $154.0K | 0.13% |
| Trexquant Investment LP | 13,689 | $84.0K | 0.01% |
| Pictet Asset Management Ltd | 13,490 | $83.0K | 0.00% |
| Amalgamated Bank | 10,875 | $67.0K | 0.00% |
| Pinz Capital Management, LP | 3,900 | $24.0K | 0.01% |
| Dark Forest Capital Management LP | 402 | $2.00K | 0.00% |
| Rockefeller Capital Management L.P. | 10 | $0 | 0.00% |
Sold out (34)
Institutions that held Standard Biotools Inc. at the end of Q1 2021 and filed for Q2 2021 without it.